NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Completed · Not applicable
Conditions studied: Cancer, Cardiovascular Disease, Neurologic Dysfunction, Congenital Abnormalities, Hearing Loss
In brief
This study is part of a larger consortium project investigating the validity and best use of next-generation sequencing (in particular, whole exome sequencing, or WES) in clinical care. This sub-project is investigating benefits and harms of providing WES diagnostic and different types of incidental findings to adult patients and parents of pediatric patients who undergo WES because they have symptoms suggesting genetic disease.
Key facts
- Study ID
- NCT01969370
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 645
- Starts
- 2012-08-01
- Expected to finish
- 2017-03-01
- Last updated by the study team
- 2017-05-03
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.